Eagle Pharmaceuticals $9.5M Securities Class Action Settlement

Eagle Pharmaceuticals $9.5M Securities Class Action Settlement

This settlement is closed. The claim deadline has passed and new claims are no longer being accepted. This page is kept for reference — see settlements that are still open →

By the Class Action Buddy Editorial Team · Last reviewed July 22, 2026

See details
Max Payout
Oct 16, 2026
Filing Deadline
Yes
Proof Required?
Eagle Pharmaceuticals is facing a $9.5 million class action securities settlement, and if you invested in Eagle Pharmaceuticals stock or securities during the relevant class period, you may be entitled to a share of that fund. Securities class action lawsuits like this one typically arise when investors allege they were misled by a company's statements — causing them to buy or hold stock at inflated prices and ultimately suffer financial losses. While full details of the settlement are still being confirmed, this type of case is common among publicly traded pharmaceutical companies. If you purchased Eagle Pharmaceuticals (EGRX) shares and lost money, it's worth checking whether you qualify for compensation. The claim deadline is October 16, 2026, so there's time to gather your investment records and submit a claim — but don't wait too long. Class Action Buddy can help you navigate the process and file your claim quickly and easily.
🎯

Looking for a settlement you can still file?

This one is closed, but our 60-second eligibility quiz finds the ones that are still open.

Check Eligibility →

Who Was Eligible?

Who the settlement covered:

  • You purchased or acquired Eagle Pharmaceuticals (EGRX) common stock or other securities during the applicable class period
  • You suffered a financial loss as a result of your investment in Eagle Pharmaceuticals securities
  • You are a U.S.-based investor or an eligible non-U.S. investor who traded on a U.S. exchange
  • You have documentation of your trades, such as brokerage statements or trade confirmations, to support your claim
  • You did not opt out of the class or otherwise exclude yourself from the settlement

How Much Did It Pay?

The total settlement fund is $9.5 million. Individual payouts will depend on factors such as how many shares you purchased, the prices at which you bought and sold, and how many eligible claimants submit valid claims. This is standard for securities settlements — the more claimants who file, the smaller each individual share of the fund. Specific per-share recovery amounts and the exact class period dates have not yet been confirmed in the information available. Once the settlement administrator publishes a formal plan of allocation, those details will clarify exactly how payouts are calculated. In the meantime, if you held Eagle Pharmaceuticals stock and experienced losses, it's worth filing a claim to preserve your right to compensation.

How this claim was filed

This settlement is closed, so the steps below are kept for reference only — they no longer lead anywhere you can file.

  • Confirm you purchased Eagle Pharmaceuticals (EGRX) securities during the relevant class period and suffered a financial loss
  • Gather your supporting documents, including brokerage statements, trade confirmations, or any records showing your purchases and sales of Eagle Pharmaceuticals stock
  • Locate the official claim form through the settlement administrator's website or court records (details pending public release)
  • Complete the claim form with your transaction details — dates, number of shares, purchase price, and sale price
  • Submit your claim form along with required proof of purchase before the October 16, 2026 deadline

Looking for something you can still claim?

This one has closed, but the open settlements list is kept current, and Class Action Buddy will tell you when a new one matches your profile.

Frequently Asked Questions

What is the deadline to file a claim for the Eagle Pharmaceuticals $9.5M Securities Class Action Settlement?

The deadline to file a claim was Oct 16, 2026, and it has passed. Claims are no longer accepted for this settlement.

Did I need documentation for the Eagle Pharmaceuticals $9.5M Securities Class Action Settlement?

Yes — this settlement required supporting documentation, and the official claim form set out what counted.

Who qualifies for the Eagle Pharmaceuticals securities settlement?

Generally, investors who purchased Eagle Pharmaceuticals (EGRX) stock or securities during the defined class period and suffered financial losses may qualify. You'll need documentation of your trades to support your claim. Exact eligibility dates will be confirmed in the official settlement notice.

How much money can I get from the Eagle Pharmaceuticals settlement?

The total settlement fund is $9.5 million. Your individual payout will depend on how many shares you held, the prices you paid, and the number of valid claims submitted. Specific per-share amounts will be outlined in the plan of allocation once it is finalized.

Do I need proof to file a claim in the Eagle Pharmaceuticals securities settlement?

Yes. Like most securities settlements, you will need to provide documentation such as brokerage statements or trade confirmations that show when you bought and sold Eagle Pharmaceuticals stock and at what prices. Make sure to gather these records before filing.

What is the deadline to file a claim for the Eagle Pharmaceuticals settlement?

The claim filing deadline is October 16, 2026. It's best to file well before this date to give yourself time to gather the required documentation and complete the claim form accurately.

What was the Eagle Pharmaceuticals securities lawsuit about?

Securities class action lawsuits typically allege that a company made false or misleading statements that caused investors to purchase stock at artificially inflated prices. When the truth came to light, the stock price dropped and investors suffered losses. The specific allegations in this case are still being confirmed, but the $9.5 million settlement reflects a resolution of those claims.

Primary source: the official settlement administrator’s website named in the court-approved class notice. We track this settlement from public settlement-notice sources; a single official administrator claim URL was not on file, so confirm the details on the official settlement website before you file.

Class Action Buddy is an independent directory and is not affiliated with, endorsed by, or sponsored by the settlement administrator or the court. This page is general information, not legal advice. See how we verify settlements.

This settlement has closed

The filing deadline for this one has passed, so no new claims are being accepted. Class Action Buddy tracks the settlements that are still open and tells you when a new one matches your profile.

See settlements that are open →